Fatigue News and Research

RSS

"Neoehrlichiosis" Internationally Diagnosed And Successfully Treated In Patients Without Immunodeficiency For The First Time

The intercellular bacteria "Candidatus Neoehrlichia", as e.g. Borrelia, can be transferred by ticks. Approx. 4.2 % of indigenous ticks are infected with this rarely explored bacterium which, until today, has been exclusively identified as pathogenic bacterium in patients with an impairment of the immune system, such as in case of leukaemia, rheumatism or after organ transplantation.

1 Mar 2016

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Novartis today announced that the United States Food and Drug Administration approved Afinitor (everolimus) tablets for the treatment of adult patients with progressive, well-differentiated, nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic.

26 Feb 2016

New ways to monitor physical activity at workplace

The science of physical activity at work remains understudied despite widespread acceptance that it plays an important role in health. Now, researchers at the Colorado School of Public Health at the University of Colorado Anschutz Medical Campus have published a comprehensive review of ways to monitor physical activity and tools for occupational exposure scientists.

26 Feb 2016

Rigel begins fostamatinib Phase 2 trial for treatment of patients with autoimmune hemolytic anemia

Rigel Pharmaceuticals Inc. today announced that it has initiated a Phase 2 clinical trial to evaluate fostamatinib, its oral SYK inhibitor, as a potential treatment for autoimmune hemolytic anemia (AIHA).

25 Feb 2016

Study: Magnesium therapy can alleviate muscular symptoms in patients with Motor Neurone Disease

Around 5,000 Motor Neurone Disease (MND) sufferers across the UK could find relief to their muscular symptoms thanks to transdermal (through the skin) magnesium therapy, say health pioneers BetterYou.

From BetterYou Ltd 25 Feb 2016

Vertical Pharmaceuticals launches breakthrough prenatal vitamin supplement: OB Complete Gold

OB Complete Gold is a breakthrough innovation in prenatal vitamin supplements that contains the advanced technology OmEGGa DHA, providing a novel egg-based DHA that comes from cage-free hens.

25 Feb 2016

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication expanding the use of IBRANCE (palbociclib) 125mg capsules, Pfizer’s metastatic breast cancer therapy.

23 Feb 2016

Lucideon adds accelerated aging of UHMWPE orthopedic implants to wear and fatigue testing services

Lucideon, the international materials technology company, is pleased to announce that it has added accelerated aging of UHMWPE polymer orthopedic implants to its range of wear and fatigue testing services.

23 Feb 2016

Patients benefit from one-on-one counseling session prior to knee or hip replacement surgery

A study at Hospital for Special Surgery finds that patients benefit from a one-on-one education session provided by a physical therapist and access to a custom web portal prior to knee or hip replacement surgery.

22 Feb 2016

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.

22 Feb 2016

Study looks at factors that affect physical recovery after participation in ultramarathon

Ultramarathon runners can expect an approximate five-to-seven-day subjective recovery post race, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif. The study also looked at factors that affect physical recovery and a runner's ability to return to full running speed after participation in an ultramarathon.

19 Feb 2016

New drug combination shows promise for patients with non-small cell lung cancer

Lung cancer is the most common cause of cancer-related death in the United States resulting in more than 158,000 deaths each year. With a 5-year survival rate at only 18 percent, the development of new and improved treatment options is needed.

18 Feb 2016

Magnesium therapy as a relaxing Mother’s day gift

This Mother’s Day, give the most important woman in your life one of the most powerful mineral relaxation rituals – magnesium therapy.

From BetterYou Ltd 17 Feb 2016

Synthetic RNA and DNA could reverse protein deficiency that causes Friedreich's ataxia

Researchers at UT Southwestern Medical Center have identified synthetic RNA and DNA that reverses the protein deficiency causing Friedreich's ataxia, a neurological disease for which there is currently no cure.

17 Feb 2016

Study highlights dual role of cytokine in inflammatory bowel disease

Small proteins that affect communication between cells play an important role in regulating inflammation that occurs during inflammatory bowel disease, according to researchers at Georgia State University, Emory University, the University of Michigan and Amgen, a biotechnology company.

17 Feb 2016

Tailored acupuncture reduces pain intensity, improves quality of life in people with fibromyalgia

Nine weekly sessions of individually tailored acupuncture lessen perceived pain intensity, and improve functional capacity and quality of life, in people with the chronic pain condition, fibromyalgia, finds research published online in Acupuncture in Medicine.

16 Feb 2016

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

Amgen today announced that Kyprolis in combination with lenalidomide and dexamethasone is now available in the UK for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

16 Feb 2016

Unpaid caregivers more likely to experience emotional, physical and financial difficulties

Unpaid family and friends who assist older people with disabilities by coordinating doctor appointments and managing medications are significantly more likely to experience emotional, physical and financial difficulties than caregivers who don't provide this type of support, new research finds.

16 Feb 2016

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

Today, the United Kingdom’s National Institute for Health and Care Excellence has issued positive guidance for the use of Medtronic insulin pump systems integrated with glucose sensors, for managing Type 1 diabetes and the avoidance of potentially life-threatening hypoglycemic episodes.

16 Feb 2016

Balancing supplementation with sunshine can help improve vitamin D levels

Health pioneers BetterYou have welcomed new guidance by the National Institute for Health and Care Excellence (NICE) highlighting that many adults in Britain have low levels of vitamin D and that some exposure to sunlight can help to build this up.

From BetterYou Ltd 15 Feb 2016

Fatigue News and Research

"Neoehrlichiosis" Internationally Diagnosed And Successfully Treated In Patients Without Immunodeficiency For The First Time

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

New ways to monitor physical activity at workplace

Rigel begins fostamatinib Phase 2 trial for treatment of patients with autoimmune hemolytic anemia

Study: Magnesium therapy can alleviate muscular symptoms in patients with Motor Neurone Disease

Vertical Pharmaceuticals launches breakthrough prenatal vitamin supplement: OB Complete Gold

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Lucideon adds accelerated aging of UHMWPE orthopedic implants to wear and fatigue testing services

Patients benefit from one-on-one counseling session prior to knee or hip replacement surgery

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

Study looks at factors that affect physical recovery after participation in ultramarathon

New drug combination shows promise for patients with non-small cell lung cancer

Magnesium therapy as a relaxing Mother’s day gift

Synthetic RNA and DNA could reverse protein deficiency that causes Friedreich's ataxia

Study highlights dual role of cytokine in inflammatory bowel disease

Tailored acupuncture reduces pain intensity, improves quality of life in people with fibromyalgia

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

Unpaid caregivers more likely to experience emotional, physical and financial difficulties

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

Balancing supplementation with sunshine can help improve vitamin D levels

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News